Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryosuke Yoshida

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2022
[Case of Unresectable Gastric Mixed Neuroendocrine Neoplasm(MiNEN)Treated with Chemotherapy]Kanto Suemori, Futoshi Uno, Kazuya Hisamatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2018
[A Case of Primary Spinddle Cell Carcinoma of the Breast]Hiroshi Kawai, Chihiro Yoshikawa, Kento Kawasaki, et al.
Cancer Immunology, Immunotherapy : CII|April 3, 2012
Mechanism of resistance to trastuzumab and molecular sensitization via ADCC activation by exogenous expression of HER2-extracellular domain in human cancer cellsRyosuke Yoshida, Hiroshi Tazawa, Yuuri Hashimoto, et al.
International Journal of Cancer|April 12, 2012
Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axisHiroshi Tazawa, Shuya Yano, Ryosuke Yoshida, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2012
A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppressionYasumoto Yamasaki, Hiroshi Tazawa, Yuuri Hashimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2022
[A Case of Intraductal Apocrine Carcinoma of the Breast]Hiroshi Kawai, Yuta Imamura, Aoi Kondoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 12, 2020
[A Case of Long-Term Survival after Para-Aortic Lymph Node Recurrence Following the Curative Resection of Gastric Cancer Treated Using Multimodality Therapy Including Salvage Surgery]Taku Noumi, Masahiro Ishizaki, Hiroaki Tanioka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 9, 2020
[Two Cases of Stage Ⅳ Occult Breast Cancer]Chihiro Yoshikawa, Hiroshi Kawai, Daisuke Mizuno, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 12, 2020
[Incidence of Catheter-Related Thrombosis in Patients with Long-Term Indwelling Central Venous Port Who Received Chemotherapies for Unresectable Advanced Digestive Cancers]Hiroaki Tanioka, Motoi Asano, Kento Kawasaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Preclinical evaluation of telomerase-specific oncolytic virotherapy for human bone and soft tissue sarcomasTsuyoshi Sasaki, Hiroshi Tazawa, Jo Hasei, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2022
[Case of Unresectable Gastric Mixed Neuroendocrine Neoplasm(MiNEN)Treated with Chemotherapy]Kanto Suemori, Futoshi Uno, Kazuya Hisamatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2018
[A Case of Primary Spinddle Cell Carcinoma of the Breast]Hiroshi Kawai, Chihiro Yoshikawa, Kento Kawasaki, et al.
Cancer Immunology, Immunotherapy : CII|April 3, 2012
Mechanism of resistance to trastuzumab and molecular sensitization via ADCC activation by exogenous expression of HER2-extracellular domain in human cancer cellsRyosuke Yoshida, Hiroshi Tazawa, Yuuri Hashimoto, et al.
International Journal of Cancer|April 12, 2012
Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axisHiroshi Tazawa, Shuya Yano, Ryosuke Yoshida, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2012
A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppressionYasumoto Yamasaki, Hiroshi Tazawa, Yuuri Hashimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2022
[A Case of Intraductal Apocrine Carcinoma of the Breast]Hiroshi Kawai, Yuta Imamura, Aoi Kondoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 12, 2020
[A Case of Long-Term Survival after Para-Aortic Lymph Node Recurrence Following the Curative Resection of Gastric Cancer Treated Using Multimodality Therapy Including Salvage Surgery]Taku Noumi, Masahiro Ishizaki, Hiroaki Tanioka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 9, 2020
[Two Cases of Stage Ⅳ Occult Breast Cancer]Chihiro Yoshikawa, Hiroshi Kawai, Daisuke Mizuno, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 12, 2020
[Incidence of Catheter-Related Thrombosis in Patients with Long-Term Indwelling Central Venous Port Who Received Chemotherapies for Unresectable Advanced Digestive Cancers]Hiroaki Tanioka, Motoi Asano, Kento Kawasaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Preclinical evaluation of telomerase-specific oncolytic virotherapy for human bone and soft tissue sarcomasTsuyoshi Sasaki, Hiroshi Tazawa, Jo Hasei, et al.
Pageof 4